Ongoing Allergan Clinical Trials' Portfolio

Eye Care

NCT02247804 - Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension

NCT02250651 - Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT02087085 - A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration (BEACON)

NCT02181504 - A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration

NCT02013791 - Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease

NCT02280473 - A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease

*NCT01426113 - A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma

*NCT01298700 - Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

*NCT01539577 - A Long-Term Safety Study of OZURDEX® in Clinical Practice

*Post-Marketing Commitment (PMC) Studies

Link Source Allergan:http://www.allerganclinicaltrials.com/ongoing/eye_care.htm